Table 1.
Demographics, task performance, and clinical characteristics of participants.
| CBTp + TAU group (n = 23, 16 men and 7 women) |
TAU-alone group (n = 17, 14 men and 3 women) |
|||
|---|---|---|---|---|
| Mean (S.D.) | Mean (S.D.) | Mean (S.D.) | Mean (S.D.) | |
| Demographics | Baseline | Follow-up | Baseline | Follow-up |
| Age (years) | 36.00 (7.66) | 39.53 (9.15) | ||
| Education (years) | 13.78 (2.81) | 13.35 (1.54) | ||
| Predicted IQa | 109.13 (8.14) | 106.71 (9.81) | ||
| Age at illness onset (years) | 23.74 (7.98) | 25.65 (8.31)b | ||
| PANSS symptoms | ||||
| Positive symptoms | 18.35 (5.16) | c15.04 (4.57) | 18.71 (3.22) | 18.06 (3.09) |
| Negative symptoms | 18.22 (4.88) | c15.91 (4.89) | 19.53 (3.97) | 20.82 (4.17) |
| General psychopathology | 33.35 (7.79) | c28.56 (7.86) | 34.65 (4.87) | 34.64 (6.12) |
| Total symptoms | 69.91 (14.87) | c59.52 (16.22) | 72.88 (9.26) | 73.52 (11.36) |
| Antipsychotic medication type | 20 patients on atypical; 3 on both atypical and typical antipsychotics | As baseline | 14 patients on atypical; 3 on both atypical and typical antipsychotics | As baseline |
| Antipsychotic dose in chlorpromazine equivalents (mg) | 521.07 (387.95) | 517.33 (344.32) | ||
a
National Adult Reading Test (Nelson and Willison, 1991).
b
PANSS: Positive and Negative Symptom Scale (Kay et al., 1987).
c
Symptom reduction (p < 0.05) in the CBTp + TAU, relative to the TAU-alone (no significant change in TAU-alone group, p > 0.05) group, at follow-up relative to baseline.